1. Home
  2. WGS vs SAM Comparison

WGS vs SAM Comparison

Compare WGS & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • SAM
  • Stock Information
  • Founded
  • WGS 2017
  • SAM 1984
  • Country
  • WGS United States
  • SAM United States
  • Employees
  • WGS N/A
  • SAM N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • SAM Beverages (Production/Distribution)
  • Sector
  • WGS Technology
  • SAM Consumer Staples
  • Exchange
  • WGS Nasdaq
  • SAM Nasdaq
  • Market Cap
  • WGS 2.4B
  • SAM 2.4B
  • IPO Year
  • WGS N/A
  • SAM 1995
  • Fundamental
  • Price
  • WGS $121.67
  • SAM $220.61
  • Analyst Decision
  • WGS Strong Buy
  • SAM Hold
  • Analyst Count
  • WGS 7
  • SAM 10
  • Target Price
  • WGS $99.29
  • SAM $254.89
  • AVG Volume (30 Days)
  • WGS 988.8K
  • SAM 293.7K
  • Earning Date
  • WGS 07-29-2025
  • SAM 07-24-2025
  • Dividend Yield
  • WGS N/A
  • SAM N/A
  • EPS Growth
  • WGS N/A
  • SAM N/A
  • EPS
  • WGS 0.05
  • SAM 6.99
  • Revenue
  • WGS $362,321,000.00
  • SAM $2,049,593,000.00
  • Revenue This Year
  • WGS $22.16
  • SAM N/A
  • Revenue Next Year
  • WGS $19.63
  • SAM $1.65
  • P/E Ratio
  • WGS $2,540.29
  • SAM $32.16
  • Revenue Growth
  • WGS 48.70
  • SAM 2.46
  • 52 Week Low
  • WGS $28.86
  • SAM $185.34
  • 52 Week High
  • WGS $123.11
  • SAM $329.55
  • Technical
  • Relative Strength Index (RSI)
  • WGS 70.52
  • SAM 60.87
  • Support Level
  • WGS $102.97
  • SAM $210.90
  • Resistance Level
  • WGS $123.22
  • SAM $225.49
  • Average True Range (ATR)
  • WGS 6.99
  • SAM 6.34
  • MACD
  • WGS 1.96
  • SAM 1.36
  • Stochastic Oscillator
  • WGS 87.25
  • SAM 87.74

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

Share on Social Networks: